Hydroxychloroquine and COVID-19: a tale of populism and obscurantism.
作者信息
Peiffer-Smadja Nathan, Rebeaud Mathieu E, Guihur Anthony, Mahamat-Saleh Yahya, Fiolet Thibault
机构信息
Université de Paris, INSERM, IAME, F-75006 Paris, France; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Infectious and Tropical Diseases Department, Bichat-Claude Bernard Hospital, AP-HP, Paris, France.
Department of Plant Molecular Biology, Faculty of Biology and Medicine, University of Lausanne, Switzerland.
出版信息
Lancet Infect Dis. 2021 May;21(5):e121. doi: 10.1016/S1473-3099(20)30866-5. Epub 2020 Nov 13.
Abstract
摘要
相似文献
1
Hydroxychloroquine and COVID-19: a tale of populism and obscurantism.
Lancet Infect Dis. 2021 May;21(5):e121. doi: 10.1016/S1473-3099(20)30866-5. Epub 2020 Nov 13.
2
The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19.
J Pharm Pract. 2022 Dec;35(6):971-978. doi: 10.1177/0897190021997399. Epub 2021 Apr 28.
3
Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency.
J Glob Antimicrob Resist. 2020 Dec;23:263-264. doi: 10.1016/j.jgar.2020.09.030. Epub 2020 Oct 17.
4
Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution.
Clin Toxicol (Phila). 2021 Jan;59(1):70-71. doi: 10.1080/15563650.2020.1748194. Epub 2020 Apr 2.
5
Response to: Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis.
J Infect Chemother. 2021 Sep;27(9):1373-1374. doi: 10.1016/j.jiac.2021.05.020. Epub 2021 Jun 4.
6
Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis - Authors reply.
J Infect Chemother. 2021 Oct;27(10):1539-1540. doi: 10.1016/j.jiac.2021.07.010. Epub 2021 Jul 16.
7
Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
Ann Pharmacother. 2020 Aug;54(8):827-831. doi: 10.1177/1060028020925558. Epub 2020 May 9.
8
Reported Adverse Drug Reactions Associated With the Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic.
Ann Intern Med. 2021 Jun;174(6):878-880. doi: 10.7326/M20-7918. Epub 2021 Jan 26.
9
What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.
J Mol Cell Biol. 2021 Jul 6;13(3):175-184. doi: 10.1093/jmcb/mjab016.
10
Hydroxychloroquine and Chloroquine.
Clin Infect Dis. 2020 Jul 28;71(15):890-891. doi: 10.1093/cid/ciaa338.
引用本文的文献
1
A Highway for Disinformation? The Alarming Exodus of Scientists from Twitter/X and its Consequences.
Stem Cell Rev Rep. 2025 May;21(4):1127-1130. doi: 10.1007/s12015-025-10864-1. Epub 2025 Mar 13.
2
Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID).
Pneumonia (Nathan). 2024 Feb 25;16(1):3. doi: 10.1186/s41479-023-00124-6.
3
Application of the PHENotype SIMulator for rapid identification of potential candidates in effective COVID-19 drug repurposing.
Heliyon. 2023 Mar;9(3):e14115. doi: 10.1016/j.heliyon.2023.e14115. Epub 2023 Mar 6.
4
Scientific Integrity Requires Publishing Rebuttals and Retracting Problematic Papers.
Stem Cell Rev Rep. 2023 Feb;19(2):568-572. doi: 10.1007/s12015-022-10465-2. Epub 2022 Oct 26.
5
Efficacy of lopinavir-ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis.
Future Virol. 2021 Dec. doi: 10.2217/fvl-2021-0066. Epub 2022 Jan 31.
6
A comprehensive review and update on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus disease 2019 (COVID-19): what do we know now in 2021?
Arch Med Sci Atheroscler Dis. 2021 Apr 6;6:e5-e13. doi: 10.5114/amsad.2021.105065. eCollection 2021.
7
Emotional eating, binge eating, physical inactivity, and vespertine chronotype are negative predictors of dietary practices during COVID-19 social isolation: A cross-sectional study.
Nutrition. 2021 Oct;90:111223. doi: 10.1016/j.nut.2021.111223. Epub 2021 Mar 9.
8
Rapid Identification of Druggable Targets and the Power of the PHENotype SIMulator for Effective Drug Repurposing in COVID-19.
Res Sq. 2021 Apr 14:rs.3.rs-287183. doi: 10.21203/rs.3.rs-287183/v1.
9
French Public Familiarity and Attitudes toward Clinical Research during the COVID-19 Pandemic.
Int J Environ Res Public Health. 2021 Mar 5;18(5):2611. doi: 10.3390/ijerph18052611.
10
Cyber harassment of female scientists will not be the new norm.
Lancet Infect Dis. 2021 Apr;21(4):457-458. doi: 10.1016/S1473-3099(20)30944-0. Epub 2020 Dec 24.
本文引用的文献
1
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
Clin Microbiol Infect. 2021 Jan;27(1):19-27. doi: 10.1016/j.cmi.2020.08.022. Epub 2020 Aug 26.
2
Death threats after a trial on chloroquine for COVID-19.
Lancet Infect Dis. 2020 Jun;20(6):661. doi: 10.1016/S1473-3099(20)30383-2.
Zotero 插件